Elevated serum sCD23 and sCD30 up to two decades prior to diagnosis associated with increased risk of non-Hodgkin lymphoma

Leukemia. 2015 Jun;29(6):1429-31. doi: 10.1038/leu.2015.2. Epub 2014 Jan 8.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Research Support, N.I.H., Intramural

MeSH terms

  • Biomarkers, Tumor / blood*
  • Case-Control Studies
  • Cohort Studies
  • Enzyme-Linked Immunosorbent Assay
  • Follow-Up Studies
  • Humans
  • Ki-1 Antigen / blood*
  • Lymphoma, Non-Hodgkin / blood*
  • Lymphoma, Non-Hodgkin / diagnosis
  • Lymphoma, Non-Hodgkin / etiology
  • Male
  • Prognosis
  • Receptors, IgE / blood*
  • Risk Factors

Substances

  • Biomarkers, Tumor
  • Ki-1 Antigen
  • Receptors, IgE